APO Research
Talk to an analyst

APO RESEARCH · REPORT

Covid-19 Vaccine

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.

The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.

Selected research

Market Structure

Global Covid-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025180 pages

Choose your research edition.

Industry ResearchCovid-19 Vaccine Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Covid-19 Vaccine Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Covid-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Covid-19 Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Covid-19 Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.

The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.

Report Includes

This report provides an overview of the global Covid-19 Vaccine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Covid-19 Vaccine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Covid-19 Vaccine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Covid-19 Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Covid-19 Vaccine Segment by Company

Moderna

CanSino Biologicals

Inovio Pharmaceuticals

Shenzhen Geno-Immune Medical Institute

GlaxoSmithKine

Pfizer

Johnson＆Johnson

Heat Biologics

Sanofi

Covid-19 Vaccine Segment by Type

DNA

Non-replicating Viral Vector

Protein Subunit

RNA

Others

Covid-19 Vaccine Segment by Application

Adults

Children

Covid-19 Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Covid-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Covid-19 Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Covid-19 Vaccine industry.

Chapter 3: Detailed analysis of Covid-19 Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Vaccinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Covid-19 Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of DNA Table 3. Key Players of Non-replicating Viral Vector Table 4. Key Players of Protein Subunit Table 3. Key Players of RNA Table 4. Key Players of Others Table 5. Global Covid-19 Vaccine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Adults Table 7. Key Players of Children Table 8. Global Covid-19 Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Covid-19 Vaccine Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Covid-19 Vaccine Market Share by Region (2021-2026) Table 11. Global Covid-19 Vaccine Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Covid-19 Vaccine Market Share by Region (2027-2032) Table 13. Covid-19 Vaccine Industry Trends Table 14. Covid-19 Vaccine Industry Drivers Table 15. Covid-19 Vaccine Industry Opportunities and Challenges Table 16. Covid-19 Vaccine Industry Restraints Table 17. Global Covid-19 Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Covid-19 Vaccine Revenue Market Share by Company (2021-2026) Table 19. Global Covid-19 Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Covid-19 Vaccine Key Company Head Office and Area Served Table 21. Global Covid-19 Vaccine Company, Product Type & Application Table 22. Global Covid-19 Vaccine Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Covid-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Covid-19 Vaccine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Covid-19 Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Covid-19 Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Covid-19 Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Covid-19 Vaccine Revenue Market Share by Type (2027-2032) Table 30. Global Covid-19 Vaccine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Covid-19 Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Covid-19 Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Covid-19 Vaccine Revenue Market Share by Application (2021-2026) Table 34. Global Covid-19 Vaccine Revenue Market Share by Application (2027-2032) Table 35. Moderna Company Information Table 36. Moderna Business Overview Table 37. Moderna Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Moderna Covid-19 Vaccine Product Portfolio Table 39. Moderna Recent Development Table 40. CanSino Biologicals Company Information Table 41. CanSino Biologicals Business Overview Table 42. CanSino Biologicals Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. CanSino Biologicals Covid-19 Vaccine Product Portfolio Table 44. CanSino Biologicals Recent Development Table 45. Inovio Pharmaceuticals Company Information Table 46. Inovio Pharmaceuticals Business Overview Table 47. Inovio Pharmaceuticals Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Inovio Pharmaceuticals Covid-19 Vaccine Product Portfolio Table 49. Inovio Pharmaceuticals Recent Development Table 50. Shenzhen Geno-Immune Medical Institute Company Information Table 51. Shenzhen Geno-Immune Medical Institute Business Overview Table 52. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product Portfolio Table 54. Shenzhen Geno-Immune Medical Institute Recent Development Table 55. GlaxoSmithKine Company Information Table 56. GlaxoSmithKine Business Overview Table 57. GlaxoSmithKine Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKine Covid-19 Vaccine Product Portfolio Table 59. GlaxoSmithKine Recent Development Table 60. Pfizer Company Information Table 61. Pfizer Business Overview Table 62. Pfizer Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pfizer Covid-19 Vaccine Product Portfolio Table 64. Pfizer Recent Development Table 65. Johnson＆Johnson Company Information Table 66. Johnson＆Johnson Business Overview Table 67. Johnson＆Johnson Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Johnson＆Johnson Covid-19 Vaccine Product Portfolio Table 69. Johnson＆Johnson Recent Development Table 70. Heat Biologics Company Information Table 71. Heat Biologics Business Overview Table 72. Heat Biologics Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Heat Biologics Covid-19 Vaccine Product Portfolio Table 74. Heat Biologics Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Sanofi Covid-19 Vaccine Product Portfolio Table 79. Sanofi Recent Development Table 80. North America Covid-19 Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 81. North America Covid-19 Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 82. North America Covid-19 Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 83. North America Covid-19 Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 84. North America Covid-19 Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Covid-19 Vaccine Market Size by Country (2021-2026) Table 86. North America Covid-19 Vaccine Market Size by Country (2027-2032) Table 87. Europe Covid-19 Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 88. Europe Covid-19 Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 89. Europe Covid-19 Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 90. Europe Covid-19 Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 91. Europe Covid-19 Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Covid-19 Vaccine Market Size by Country (2021-2026) Table 93. Europe Covid-19 Vaccine Market Size by Country (2027-2032) Table 94. China Covid-19 Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 95. China Covid-19 Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 96. China Covid-19 Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 97. China Covid-19 Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Covid-19 Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 99. Asia Covid-19 Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 100. Asia Covid-19 Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 101. Asia Covid-19 Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 102. Asia Covid-19 Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Covid-19 Vaccine Market Size by Country (2021-2026) Table 104. Asia Covid-19 Vaccine Market Size by Country (2027-2032) Table 105. South America, Middle East & Africa Covid-19 Vaccine Market Size by Type (2021-2026) & (US$ Million) Table 106. South America, Middle East & Africa Covid-19 Vaccine Market Size by Type (2027-2032) & (US$ Million) Table 107. South America, Middle East & Africa Covid-19 Vaccine Market Size by Application (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Covid-19 Vaccine Market Size by Application (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Covid-19 Vaccine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. South America, Middle East & Africa Covid-19 Vaccine Market Size by Country (2021-2026) Table 111. South America, Middle East & Africa Covid-19 Vaccine Market Size by Country (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Covid-19 Vaccine Product Image Figure 2. Global Covid-19 Vaccine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Covid-19 Vaccine Market Share by Type: 2025 VS 2032 Figure 4. DNA Image Figure 5. Non-replicating Viral Vector Image Figure 6. Protein Subunit Image Figure 7. RNA Image Figure 8. Others Image Figure 9. Global Covid-19 Vaccine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Covid-19 Vaccine Market Share by Application: 2025 VS 2032 Figure 11. Adults Image Figure 12. Children Image Figure 13. Global Covid-19 Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 15. Global Covid-19 Vaccine Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Covid-19 Vaccine Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Covid-19 Vaccine Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Covid-19 Vaccine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Covid-19 Vaccine Revenue Market Share by Type (2021-2032) Figure 22. Global Covid-19 Vaccine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Covid-19 Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 25. North America Covid-19 Vaccine Market Share by Type (2021-2032) Figure 26. North America Covid-19 Vaccine Market Share by Application (2021-2032) Figure 27. North America Covid-19 Vaccine Market Share by Country (2021-2032) Figure 28. United States Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 29. Canada Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 31. Europe Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 32. Europe Covid-19 Vaccine Market Share by Type (2021-2032) Figure 33. Europe Covid-19 Vaccine Market Share by Application (2021-2032) Figure 34. Europe Covid-19 Vaccine Market Share by Country (2021-2032) Figure 35. Germany Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 36. France Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 38. Italy Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 39. Russia Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 41. China Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 42. China Covid-19 Vaccine Market Share by Type (2021-2032) Figure 43. China Covid-19 Vaccine Market Share by Application (2021-2032) Figure 44. Asia Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 45. Asia Covid-19 Vaccine Market Share by Type (2021-2032) Figure 46. Asia Covid-19 Vaccine Market Share by Application (2021-2032) Figure 47. Asia Covid-19 Vaccine Market Share by Country (2021-2032) Figure 48. Japan Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 52. India Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 53. Australia Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Covid-19 Vaccine Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Covid-19 Vaccine Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Covid-19 Vaccine Market Share by Country (2021-2032) Figure 58. Brazil Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 63. UAE Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 65. Chile Covid-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • DNA
  • Non-replicating Viral Vector
  • Protein Subunit
  • RNA
  • Others
Applications
  • Adults
  • Children
Companies covered
  • Moderna
  • CanSino Biologicals
  • Inovio Pharmaceuticals
  • Shenzhen Geno-Immune Medical Institute
  • GlaxoSmithKine
  • Pfizer
  • Johnson＆Johnson
  • Heat Biologics
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 DNA
  5. 1.2.3 Non-replicating Viral Vector
  6. 1.2.4 Protein Subunit
  7. 1.2.5 RNA
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Covid-19 Vaccine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Adults
  12. 1.3.3 Children
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Covid-19 Vaccine Growth Trends by Region
  15. 1.5.1 Global Covid-19 Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Covid-19 Vaccine Market Size by Region (2021-2026)
  17. 1.5.3 Covid-19 Vaccine Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Covid-19 Vaccine Market Dynamics
  1. 2.1 Covid-19 Vaccine Industry Trends
  2. 2.2 Covid-19 Vaccine Industry Drivers
  3. 2.3 Covid-19 Vaccine Industry Opportunities and Challenges
  4. 2.4 Covid-19 Vaccine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Covid-19 Vaccine Revenue by Company (2021-2026)
  2. 3.2 Global Covid-19 Vaccine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Covid-19 Vaccine Key Company Head office and Area Served
  4. 3.4 Global Covid-19 Vaccine Company, Product Type & Application
  5. 3.5 Global Covid-19 Vaccine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Covid-19 Vaccine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Covid-19 Vaccine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Covid-19 Vaccine Tier 1, Tier 2, and Tier 3
4 Covid-19 Vaccine Market by Type
  1. 4.1 Global Covid-19 Vaccine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Covid-19 Vaccine Market Size by Type (2021-2032)
  3. 4.3 Global Covid-19 Vaccine Market Size Share by Type (2021-2032)
5 Covid-19 Vaccine Market by Application
  1. 5.1 Global Covid-19 Vaccine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Covid-19 Vaccine Market Size by Application (2021-2032)
  3. 5.3 Global Covid-19 Vaccine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Moderna
  2. 6.1.1 Moderna Company Information
  3. 6.1.2 Moderna Business Overview
  4. 6.1.3 Moderna Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Moderna Covid-19 Vaccine Product Portfolio
  6. 6.1.5 Moderna Recent Developments
  7. 6.2 CanSino Biologicals
  8. 6.2.1 CanSino Biologicals Company Information
  9. 6.2.2 CanSino Biologicals Business Overview
  10. 6.2.3 CanSino Biologicals Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 CanSino Biologicals Covid-19 Vaccine Product Portfolio
  12. 6.2.5 CanSino Biologicals Recent Developments
  13. 6.3 Inovio Pharmaceuticals
  14. 6.3.1 Inovio Pharmaceuticals Company Information
  15. 6.3.2 Inovio Pharmaceuticals Business Overview
  16. 6.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Product Portfolio
  18. 6.3.5 Inovio Pharmaceuticals Recent Developments
  19. 6.4 Shenzhen Geno-Immune Medical Institute
  20. 6.4.1 Shenzhen Geno-Immune Medical Institute Company Information
  21. 6.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
  22. 6.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product Portfolio
  24. 6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments
  25. 6.5 GlaxoSmithKine
  26. 6.5.1 GlaxoSmithKine Company Information
  27. 6.5.2 GlaxoSmithKine Business Overview
  28. 6.5.3 GlaxoSmithKine Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKine Covid-19 Vaccine Product Portfolio
  30. 6.5.5 GlaxoSmithKine Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pfizer Covid-19 Vaccine Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Johnson＆Johnson
  38. 6.7.1 Johnson＆Johnson Company Information
  39. 6.7.2 Johnson＆Johnson Business Overview
  40. 6.7.3 Johnson＆Johnson Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Johnson＆Johnson Covid-19 Vaccine Product Portfolio
  42. 6.7.5 Johnson＆Johnson Recent Developments
  43. 6.8 Heat Biologics
  44. 6.8.1 Heat Biologics Company Information
  45. 6.8.2 Heat Biologics Business Overview
  46. 6.8.3 Heat Biologics Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Heat Biologics Covid-19 Vaccine Product Portfolio
  48. 6.8.5 Heat Biologics Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Covid-19 Vaccine Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sanofi Covid-19 Vaccine Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
7 North America
  1. 7.1 North America Covid-19 Vaccine Market Size (2021-2032)
  2. 7.2 North America Covid-19 Vaccine Market Size by Type
  3. 7.2.1 North America Covid-19 Vaccine Market Size by Type (2021-2026)
  4. 7.2.2 North America Covid-19 Vaccine Market Size by Type (2027-2032)
  5. 7.2.3 North America Covid-19 Vaccine Market Share by Type (2021-2032)
  6. 7.3 North America Covid-19 Vaccine Market Size by Application
  7. 7.3.1 North America Covid-19 Vaccine Market Size by Application (2021-2026)
  8. 7.3.2 North America Covid-19 Vaccine Market Size by Application (2027-2032)
  9. 7.3.3 North America Covid-19 Vaccine Market Share by Application (2021-2032)
  10. 7.4 North America Covid-19 Vaccine Market Size by Country
  11. 7.4.1 North America Covid-19 Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Covid-19 Vaccine Market Size by Country (2021-2026)
  13. 7.4.3 North America Covid-19 Vaccine Market Size by Country (2027-2032)
  14. 7.4.4 North America Covid-19 Vaccine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Covid-19 Vaccine Market Size (2021-2032)
  2. 8.2 Europe Covid-19 Vaccine Market Size by Type
  3. 8.2.1 Europe Covid-19 Vaccine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Covid-19 Vaccine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Covid-19 Vaccine Market Share by Type (2021-2032)
  6. 8.3 Europe Covid-19 Vaccine Market Size by Application
  7. 8.3.1 Europe Covid-19 Vaccine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Covid-19 Vaccine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Covid-19 Vaccine Market Share by Application (2021-2032)
  10. 8.4 Europe Covid-19 Vaccine Market Size by Country
  11. 8.4.1 Europe Covid-19 Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Covid-19 Vaccine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Covid-19 Vaccine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Covid-19 Vaccine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Covid-19 Vaccine Market Size (2021-2032)
  2. 9.2 China Covid-19 Vaccine Market Size by Type
  3. 9.2.1 China Covid-19 Vaccine Market Size by Type (2021-2026)
  4. 9.2.2 China Covid-19 Vaccine Market Size by Type (2027-2032)
  5. 9.2.3 China Covid-19 Vaccine Market Share by Type (2021-2032)
  6. 9.3 China Covid-19 Vaccine Market Size by Application
  7. 9.3.1 China Covid-19 Vaccine Market Size by Application (2021-2026)
  8. 9.3.2 China Covid-19 Vaccine Market Size by Application (2027-2032)
  9. 9.3.3 China Covid-19 Vaccine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Covid-19 Vaccine Market Size (2021-2032)
  2. 10.2 Asia Covid-19 Vaccine Market Size by Type
  3. 10.2.1 Asia Covid-19 Vaccine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Covid-19 Vaccine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Covid-19 Vaccine Market Share by Type (2021-2032)
  6. 10.3 Asia Covid-19 Vaccine Market Size by Application
  7. 10.3.1 Asia Covid-19 Vaccine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Covid-19 Vaccine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Covid-19 Vaccine Market Share by Application (2021-2032)
  10. 10.4 Asia Covid-19 Vaccine Market Size by Country
  11. 10.4.1 Asia Covid-19 Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Covid-19 Vaccine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Covid-19 Vaccine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Covid-19 Vaccine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Covid-19 Vaccine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Covid-19 Vaccine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Covid-19 Vaccine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Covid-19 Vaccine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Covid-19 Vaccine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Covid-19 Vaccine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Covid-19 Vaccine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Covid-19 Vaccine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Covid-19 Vaccine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Covid-19 Vaccine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Covid-19 Vaccine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Covid-19 Vaccine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Covid-19 Vaccine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Covid-19 Vaccine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst